Nektar Therapeutics NKTR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 11/25/22 EST
3.24UNCH (UNCH)
Close
3.24quote price arrow down-0.04 (-1.22%)
Volume
355,076
52 week range
2.96 - 15.94
Loading...
  • Open3.27
  • Day High3.30
  • Day Low3.23
  • Prev Close3.28
  • 52 Week High15.94
  • 52 Week High Date12/23/21
  • 52 Week Low2.96
  • 52 Week Low Date09/29/22

Key Stats

  • Market Cap608.973M
  • Shares Out187.95M
  • 10 Day Average Volume1.28M
  • Dividend-
  • Dividend Yield-
  • Beta1.08
  • YTD % Change-76.02

KEY STATS

  • Open3.27
  • Day High3.30
  • Day Low3.23
  • Prev Close3.28
  • 52 Week High15.94
  • 52 Week High Date12/23/21
  • 52 Week Low2.96
  • 52 Week Low Date09/29/22
  • Market Cap608.973M
  • Shares Out187.95M
  • 10 Day Average Volume1.28M
  • Dividend-
  • Dividend Yield-
  • Beta1.08
  • YTD % Change-76.02

RATIOS/PROFITABILITY

  • EPS (TTM)-2.44
  • P/E (TTM)-1.33
  • Fwd P/E (NTM)-2.37
  • EBITDA (TTM)-298.973M
  • ROE (TTM)-74.83%
  • Revenue (TTM)95.041M
  • Gross Margin (TTM)77.31%
  • Net Margin (TTM)-477.85%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date02/27/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nektar Therapeutics

 

Profile

MORE
Nektar Therapeutics is a research-based biopharmaceutical company, which is focused on discovering and developing medicines in areas of unmet medical need. The Company's research and development pipeline of new investigational drugs includes potential therapies for oncology, immunology and virology. In oncology, it is studying several immuno-oncology (I-O) drug candidates, including bempegaldesleukin, NKTR-255 and NKTR-262. In immunology, it is focused on addressing...
Robert Chess
Independent Chairman of the Board
Howard Robin
President, Chief Executive Officer, Director
Jillian Thomsen
Chief Financial Officer, Senior Vice President
Address
455 Mission Bay Blvd S
San Francisco, CA
94158-2158
United States

Top Peers

SYMBOLLASTCHG%CHG
SGMO
Sangamo Therapeutics Inc
3.56+0.01+0.28%
SRNE
Sorrento Therapeutics Inc
1.35-0.03-2.17%
AVEO
Aveo Pharmaceuticals Inc
14.87+0.01+0.07%
ALEC
Alector Inc
7.75-0.02-0.26%
ADMA
ADMA Biologics Inc
3.25+0.09+2.85%